MedTrace Logo

Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease

NCT05355610 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2022-05-02

No results posted yet for this study

Summary

Intractable symptoms of Meniere's disease will be treated with intratympanic steroids.

At the same time intratympanic dexamethasone will be used to rescue hearing

Conditions

  • Vestibular Disorder Preservation

Interventions

DRUG

Gentamicin

Intratympanic gentamicin and dexamethasone administered in two doses one week apart

DRUG

Dexamethasone

Intratympanic gentamicin and dexamethasone administered in two doses one week apart

Sponsors & Collaborators

  • Combined Military Hospital Quetta

    lead OTHER

Principal Investigators

  • Zeeshan Ayub, FCPS · CMH Quetta

  • Zeeshan Ayub, FCPS · CMH Quetta

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
24 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-04-22
Completion
2022-05-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05355610 on ClinicalTrials.gov